Khan, Salman, et al. “Failure of the PD-1 Blocking Agent Pembrolizumab to Benefit a Patient With Renal Squamous Cell Cancer”. European Journal of Case Reports in Internal Medicine, vol. 11, no. 7, June 2024, https://doi.org/10.12890/2024_004619.